Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1983 2
1985 1
1986 3
1987 4
1988 1
1989 2
1990 4
1991 2
1992 6
1993 6
1994 7
1995 5
1996 8
1997 7
1998 9
1999 5
2000 6
2001 7
2002 5
2003 7
2004 6
2005 10
2006 5
2007 4
2008 6
2009 7
2010 7
2011 8
2012 8
2013 13
2014 7
2015 6
2016 9
2017 7
2018 9
2019 9
2020 6
2021 10
2022 4
Text availability
Article attribute
Article type
Publication date

Search Results

217 results
Results by year
Filters applied: . Clear all
Page 1
Therapeutic breakthroughs for metastatic thyroid cancer.
Tiedje V, Fagin JA. Tiedje V, et al. Among authors: fagin ja. Nat Rev Endocrinol. 2020 Feb;16(2):77-78. doi: 10.1038/s41574-019-0307-2. Nat Rev Endocrinol. 2020. PMID: 31819229 Free PMC article. Review.
Biologic and Clinical Perspectives on Thyroid Cancer.
Fagin JA, Wells SA Jr. Fagin JA, et al. N Engl J Med. 2016 Sep 15;375(11):1054-67. doi: 10.1056/NEJMra1501993. N Engl J Med. 2016. PMID: 27626519 Free PMC article. Review. No abstract available.
Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Landa I, Ibrahimpasic T, Boucai L, Sinha R, Knauf JA, Shah RH, Dogan S, Ricarte-Filho JC, Krishnamoorthy GP, Xu B, Schultz N, Berger MF, Sander C, Taylor BS, Ghossein R, Ganly I, Fagin JA. Landa I, et al. Among authors: fagin ja. J Clin Invest. 2016 Mar 1;126(3):1052-66. doi: 10.1172/JCI85271. Epub 2016 Feb 15. J Clin Invest. 2016. PMID: 26878173 Free PMC article.
SWI/SNF Complex Mutations Promote Thyroid Tumor Progression and Insensitivity to Redifferentiation Therapies.
Saqcena M, Leandro-Garcia LJ, Maag JLV, Tchekmedyian V, Krishnamoorthy GP, Tamarapu PP, Tiedje V, Reuter V, Knauf JA, de Stanchina E, Xu B, Liao XH, Refetoff S, Ghossein R, Chi P, Ho AL, Koche RP, Fagin JA. Saqcena M, et al. Among authors: fagin ja. Cancer Discov. 2021 May;11(5):1158-1175. doi: 10.1158/2159-8290.CD-20-0735. Epub 2020 Dec 14. Cancer Discov. 2021. PMID: 33318036 Free PMC article.
Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial.
Wells SA Jr, Robinson BG, Gagel RF, Dralle H, Fagin JA, Santoro M, Baudin E, Elisei R, Jarzab B, Vasselli JR, Read J, Langmuir P, Ryan AJ, Schlumberger MJ. Wells SA Jr, et al. Among authors: fagin ja. J Clin Oncol. 2012 Jan 10;30(2):134-41. doi: 10.1200/JCO.2011.35.5040. Epub 2011 Oct 24. J Clin Oncol. 2012. PMID: 22025146 Free PMC article. Clinical Trial.
Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical Studies.
Landa I, Pozdeyev N, Korch C, Marlow LA, Smallridge RC, Copland JA, Henderson YC, Lai SY, Clayman GL, Onoda N, Tan AC, Garcia-Rendueles MER, Knauf JA, Haugen BR, Fagin JA, Schweppe RE. Landa I, et al. Among authors: fagin ja. Clin Cancer Res. 2019 May 15;25(10):3141-3151. doi: 10.1158/1078-0432.CCR-18-2953. Epub 2019 Feb 8. Clin Cancer Res. 2019. PMID: 30737244 Free PMC article.
Tipifarnib Inhibits HRAS-Driven Dedifferentiated Thyroid Cancers.
Untch BR, Dos Anjos V, Garcia-Rendueles MER, Knauf JA, Krishnamoorthy GP, Saqcena M, Bhanot UK, Socci ND, Ho AL, Ghossein R, Fagin JA. Untch BR, et al. Among authors: fagin ja. Cancer Res. 2018 Aug 15;78(16):4642-4657. doi: 10.1158/0008-5472.CAN-17-1925. Epub 2018 May 14. Cancer Res. 2018. PMID: 29760048 Free PMC article.
Genetics of Human Thyroid Cancer Cell Lines-Response.
Landa I, Pozdeyev N, Knauf JA, Haugen BR, Fagin JA, Schweppe RE. Landa I, et al. Among authors: fagin ja. Clin Cancer Res. 2019 Nov 15;25(22):6883-6884. doi: 10.1158/1078-0432.CCR-19-2531. Clin Cancer Res. 2019. PMID: 31732665 Free PMC article. No abstract available.
217 results